Sympathetic neural mechanisms in white-coat hypertension - PubMed (original) (raw)
Sympathetic neural mechanisms in white-coat hypertension
Paul A Smith et al. J Am Coll Cardiol. 2002.
Free article
Abstract
Objectives: This study planned to establish whether sympathetic hyperactivity exists in white-coat hypertension (WHT) in the clinical setting, relative to matched groups with normotension (NT) and untreated essential hypertension (EHT).
Background: White-coat hypertension differs from EHT by the presence of normal ambulatory blood pressure. Sympathetic hyperactivity exists in patients with EHT in the clinical setting and is believed to contribute to the development of target organ damage. Similar organ damage has been reported in WHT, yet little is known about sympathetic neural activity in this condition.
Methods: Using microneurography, we examined groups of 12 matched subjects with WHT, EHT and NT during the same clinical setting to quantify muscle sympathetic nerve activity as multiunit discharge (MSNA) and single units (s-MSNA).
Results: The s-MSNA in WHT (54 +/- 4.2 impulses/100 beats) was greater (p < 0.05) than in NT (37 +/- 5.4 impulses/100 beats) despite similar age and body mass index (BMI). The EHT values of s-MSNA (73 +/- 5.2 impulses/100 beats) were significantly (p < 0.05) greater than in WHT despite similar age, BMI and blood pressure levels. The MSNA followed a similar trend. White-coat hypertension had a similar cardiac baroreceptor reflex sensitivity to NT, but this was impaired in EHT relative to both NT and WHT.
Conclusions: It was shown, in the clinical setting, that central sympathetic hyperactivity exists in WHT, albeit to a lesser degree than EHT. These findings suggest that WHT may not be entirely benign and that the observed sympathetic hyperactivity may be responsible for development of target organ damage in this group of patients.
Similar articles
- Relationship between central sympathetic activity and stages of human hypertension.
Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DA. Smith PA, et al. Am J Hypertens. 2004 Mar;17(3):217-22. doi: 10.1016/j.amjhyper.2003.10.010. Am J Hypertens. 2004. PMID: 15001194 - Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension.
Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DA. Huggett RJ, et al. Circulation. 2003 Dec 23;108(25):3097-101. doi: 10.1161/01.CIR.0000103123.66264.FE. Epub 2003 Dec 15. Circulation. 2003. PMID: 14676139 - Single-unit sympathetic discharge : quantitative assessment in human hypertensive disease.
Greenwood JP, Stoker JB, Mary DA. Greenwood JP, et al. Circulation. 1999 Sep 21;100(12):1305-10. doi: 10.1161/01.cir.100.12.1305. Circulation. 1999. PMID: 10491375 - The activity of single vasoconstrictor nerve units in hypertension.
Mary DA, Stoker JB. Mary DA, et al. Acta Physiol Scand. 2003 Mar;177(3):367-76. doi: 10.1046/j.1365-201X.2003.01082.x. Acta Physiol Scand. 2003. PMID: 12609008 Review. - Use of microneurography to evaluate sympathetic activity in hypertension: a brief review.
Yucha CB. Yucha CB. Appl Psychophysiol Biofeedback. 2000 Mar;25(1):55-63. doi: 10.1023/a:1009537506603. Appl Psychophysiol Biofeedback. 2000. PMID: 10832510 Review.
Cited by
- Hypertension phenotypes and adverse pregnancy outcome-related office and ambulatory blood pressure thresholds during pregnancy: a retrospective cohort study.
Fang Y, Zuo L, Duan H, Huang C, Wen J, Yang Q, Han C, Lv L, Zhou X. Fang Y, et al. Hypertens Res. 2024 Aug 16. doi: 10.1038/s41440-024-01837-x. Online ahead of print. Hypertens Res. 2024. PMID: 39152252 - The Influence of Factors such as Anxiety on the White Coat Effect during the Treatment of Patients with Hypertension.
Xu D, Qiu H, Li Z, Yan P, Xu H, Gu Y, Lin H. Xu D, et al. Rev Cardiovasc Med. 2022 Oct 25;23(11):359. doi: 10.31083/j.rcm2311359. eCollection 2022 Nov. Rev Cardiovasc Med. 2022. PMID: 39076195 Free PMC article. - Orthostatic hypotension, orthostatic hypertension, and ambulatory blood pressure in patients with chronic kidney disease in CRIC.
Ghazi L, Cohen JB, Townsend RR, Drawz PE, Rahman M, Pradhan N, Cohen DL, Weir MR, Rincon-Choles H, Juraschek SP. Ghazi L, et al. J Hypertens. 2024 Feb 1;42(2):329-336. doi: 10.1097/HJH.0000000000003604. Epub 2023 Oct 26. J Hypertens. 2024. PMID: 37889527 - White Coat Effect: Is It Because of the Hospital Setting, or Is It Physician-Induced?
Singh M, Singh N, Pahuja H, Arora R, Anshul, Patel H. Singh M, et al. Cureus. 2023 Apr 26;15(4):e38144. doi: 10.7759/cureus.38144. eCollection 2023 Apr. Cureus. 2023. PMID: 37257162 Free PMC article. - Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions.
Ma J, Li Y, Yang X, Liu K, Zhang X, Zuo X, Ye R, Wang Z, Shi R, Meng Q, Chen X. Ma J, et al. Signal Transduct Target Ther. 2023 Apr 20;8(1):168. doi: 10.1038/s41392-023-01430-7. Signal Transduct Target Ther. 2023. PMID: 37080965 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials